Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ZLAB
ZLAB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ZLAB News
Zai Lab Partners with Amgen to Evaluate Lung Cancer Therapy
1d ago
Yahoo Finance
ZL-1503 Shows Promise as First-in-Class Treatment at IMMUNOLOGY2026
2d ago
Newsfilter
Zoci Antibody Drug Shows Promising Efficacy in Small Cell Lung Cancer
2d ago
Newsfilter
Zai Lab Partners with Amgen for Global Clinical Trial
Apr 01 2026
seekingalpha
Zai Lab Collaborates with Amgen for Clinical Trial
Apr 01 2026
Newsfilter
Zai Lab Showcases Innovative ADCs at AACR 2026
Mar 17 2026
Newsfilter
Zai Lab's Q4 2025 Earnings Call Highlights Global Innovation and Pipeline Progress
Feb 26 2026
seekingalpha
Zai Lab Scheduled to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
ZAI LAB LTD: CITIGROUP LOWERS TARGET PRICE FROM $58 TO $53
Feb 20 2026
moomoo
Oncolytics Biotech Receives FDA Fast Track Designation
Feb 05 2026
PRnewswire
FDA Accelerates Oncology Drug Approvals, Boosting Market Potential
Feb 05 2026
Newsfilter
ClearBridge International Growth Strategy Underperforms in Q4 2025
Feb 04 2026
seekingalpha
Oversold Stocks in Healthcare Sector Present Buying Opportunities
Feb 03 2026
Benzinga
Healthcare Sector Outperforms S&P 500 with 12.52% Gain and 3.20 Health Score
Jan 14 2026
seekingalpha
Seeking Alpha Releases Q4 Stock Ratings, Micron and Others Rated Strong Buy
Jan 12 2026
seekingalpha
Zai Lab Receives NMPA Approval for AUGTYRO™ in NTRK-Positive Solid Tumors
Jan 06 2026
Newsfilter
Show More News
